Welcome to our dedicated page for American Express Co SEC filings (Ticker: AXP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Express Company filings document the regulatory record of a global payments company with consumer, small-business, commercial, and merchant-network activities. Current reports and Regulation FD disclosures cover operating results, supplemental financial data, Card Member loan delinquency and write-off statistics for U.S. Consumer and U.S. Small Business portfolios, and risk disclosures tied to spending volumes, partnerships, regulation, litigation, competition, and reputation.
Its filings also address capital structure and governance, including fixed-to-floating rate note issuances under shelf registration materials, common-share dividend actions, annual meeting voting results, director elections, auditor ratification, executive compensation votes, shareholder proposals, and related proxy disclosures.
American Express (AXP) disclosed insider activity by its Chairman and CEO. On 11/03/2025, the executive reported a gift of 10,688 shares of common stock (code G), leaving 163,292 shares beneficially owned directly after the transaction.
Separately, on 10/31/2025, 224,551 employee stock options became reportable at an exercise price of $148.45 and an expiration of 10/31/2029. These options stem from an October 2022 performance stock option grant, with 75% vested based on performance criteria; the remaining 25% are subject to meeting criteria and continued employment through 10/31/2026.
American Express (AXP) reported an insider equity award by its Chief Legal Officer. On 10/31/2025, the officer acquired 52,395 employee stock options at an exercise price of $148.45 per share, reported as a Form 4 transaction coded “A”. The options are listed as Direct ownership.
The options become exercisable on 10/31/2026 and expire on 10/31/2029, covering 52,395 shares of common stock. According to the footnote, this reflects vesting of a Performance Stock Option grant made in October 2022, with 75% of the award having vested based on performance criteria. The remaining 25% is subject to meeting performance criteria and continued employment through October 31, 2026.
American Express (AXP) reported an insider transaction by its Chief Marketing Officer under a 10b5-1 trading plan adopted on July 25, 2025. On October 31, 2025, the officer exercised 50,000 employee stock options at $65.43 per share and sold 50,000 common shares in multiple trades.
Sales were executed in tranches, including 1,083 shares at a weighted average price of $356.94, 4,971 at $358.10, 4,234 at $359.04, 15,532 at $360.09, 15,196 at $360.79, and 8,984 at $361.57. Following the transactions, the officer reported 85,576.72 shares held directly and 2,171.23 shares held indirectly via a 401(k) plan. The option related to 50,000 shares and carried an expiration date of April 29, 2026.
American Express (AXP) reported a Form 4 for an officer (Pres., Enterprise Shared Serv.) showing an acquisition of 52,395 employee stock options on 10/31/2025. The options carry a $148.45 exercise price, become exercisable on 10/31/2026, and expire on 10/31/2029. Following the transaction, the reporting person directly holds 52,395 derivative securities.
The filing notes these relate to a Performance Stock Option award granted in October 2022, of which 75% has vested based on specified performance criteria. The remaining 25% is contingent on meeting performance goals and the reporting person’s continued employment through October 31, 2026.
American Express (AXP) reported an insider equity award. The company’s Group President, GMNS, reported 67,365 employee stock options with an exercise price of $148.45 from a performance-based grant originally made in October 2022.
The options are first exercisable on 10/31/2026 and expire on 10/31/2029. According to the filing, 75% of the award has vested based on performance criteria, while the remaining 25% is contingent on meeting performance goals and continued employment through 10/31/2026.
American Express (AXP) reported an insider equity award by its Group President, Global Consumer Services. On 10/31/2025, the officer acquired 67,365 employee stock options at an exercise price of $148.45 per share, recorded as Direct ownership.
The options are listed as exercisable beginning 10/31/2026 and expiring on 10/31/2029, with a post-transaction balance of 67,365 derivative securities. According to the note, the award was granted in October 2022 and is tied to performance: 75% has vested, while the remaining 25% depends on meeting performance criteria and continued employment through October 31, 2026.
American Express (AXP) reported an insider equity award. A company officer acquired 52,395 employee stock options on 10/31/2025 at a $148.45 exercise price, coded A(1). The options are first exercisable on 10/31/2026 and expire on 10/31/2029, with 52,395 derivative securities beneficially owned directly after the transaction.
According to the footnote, these options relate to a performance stock option grant from October 2022, of which 75% has vested based on performance criteria. The remaining 25% depends on meeting performance criteria and continued employment through October 31, 2026.
American Express (AXP) reported an insider equity transaction by its Group President, U.S. Consumer Services. On 10/31/2025, the officer acquired 52,395 employee stock options at an exercise price of $148.45. These options become exercisable on 10/31/2026 and expire on 10/31/2029.
The filing notes that the award stems from performance stock options granted in October 2022, of which 75% have vested based on specified performance criteria. The remaining 25% depend on meeting performance conditions and continued employment through October 31, 2026.
American Express (AXP) — Form 144 notice: A holder filed to sell 50,000 shares of common stock, with an aggregate market value of $17,944,000. The shares were acquired on 10/31/2025 via cash exercise of stock options from the issuer, and the planned sale date is 10/31/2025.
The proposed sales are to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE. This filing is a notice of potential sales under Rule 144 and does not represent a company offering. The table lists 688,851,653 shares outstanding.
American Express submitted a Form 13F disclosing institutional holdings. The report lists 2 holdings with a combined reported market value of $1,275,236,260. The filing was signed by James J. Killerlane III on 10-31-2025.